Infection rate Long term (30 to 365 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood loss during the procedure · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Length of hospital stay · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Procedure‐related costs · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Morbidity (GOS) · people with unruptured intracranial aneurysms
1 finding from 1 review
Functional outcomes · people with stroke upon awakening
Intravenous thrombolytic treatment leads to higher independent functional outcome at end of compared with standard medical care (high certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage at · people with stroke upon awakening
Intravenous thrombolytic treatment showed no clear difference in symptomatic intracranial haemorrhage at compared with standard medical care (high certainty).
1 finding from 1 review
Death at · people with stroke upon awakening
Intravenous thrombolytic treatment showed no clear difference in death at compared with standard medical care (high certainty).
1 finding from 1 review
Functional outcomes · acute ischaemic stroke endovascular treatment (long‐term)
3 findings from 1 review
no estimate extracted
1 study · 90 participants
Very low
RR 1.21 [0.93, 1.58]
4 studies · 625 participants
Low
no estimate extracted
7 studies · 978 participants
Low
Neurological impairment · acute ischaemic stroke endovascular treatment (long‐term)
The review found no eligible studies for this question.
2 findings from 1 review
Stroke‐related mortality · acute ischaemic stroke endovascular treatment (long‐term)
General anaesthesia showed no clear difference in stroke‐related mortality compared with non‐general anaesthesia (low certainty).
2 findings from 1 review
Intracranial haemorrhage · acute ischaemic stroke endovascular treatment (long‐term)
The review found no eligible studies for this question.
2 findings from 1 review
Target artery revascularisation status · acute ischaemic stroke endovascular treatment (long‐term)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to revascularisation · acute ischaemic stroke endovascular treatment (long‐term)
The review found no eligible studies for this question.
2 findings from 1 review
Adverse events · acute ischaemic stroke endovascular treatment (long‐term)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Target artery revascularisation (dichotomous; mTICI 2b–3) · acute ischaemic stroke endovascular treatment (long‐term)
General anaesthesia probably leads to higher target artery revascularisation (dichotomous; mTICI 2b–3) compared with non‐general anaesthesia (moderate certainty).
1 finding from 1 review
Adverse events (haemodynamic instability) · acute ischaemic stroke endovascular treatment (long‐term)
General anaesthesia may leads to lower adverse events (haemodynamic instability) compared with non‐general anaesthesia (low certainty).
1 finding from 1 review
Morbidity (GOS) · people with unruptured intracranial aneurysms
1 finding from 1 review
Death · people with unruptured intracranial aneurysms
1 finding from 1 review
Stroke · people with unruptured intracranial aneurysms
1 finding from 1 review